MeSH Review:
Vasoconstriction
Ames,
Sarau,
Chambers,
Willette,
Aiyar,
Romanic,
Louden,
Foley,
Sauermelch,
Coatney,
Ao,
Disa,
Holmes,
Stadel,
Martin,
Liu,
Glover,
Wilson,
McNulty,
Ellis,
Elshourbagy,
Shabon,
Trill,
Hay,
Ohlstein,
Bergsma,
Douglas,
Thomas,
Hansen,
Victor,
Iwamoto,
Kita,
Zhang,
Blaustein,
Arai,
Yoshida,
Wakimoto,
Komuro,
Katsuragi,
Kriz,
Costoli,
Sgoifo,
Stilli,
Flugge,
Adriani,
Laviola,
Fuchs,
Pedrazzini,
Musso,
Goldstein,
Roon,
Offen,
Ramadan,
Phebus,
Johnson,
Schaus,
Ferrari,
Reubi,
Gugger,
Waser,
Schaer,
Walther,
Peter,
Winter,
Höltje,
Paulmann,
Grohmann,
Vowinckel,
Alamo-Bethencourt,
Wilhelm,
Ahnert-Hilger,
Bader,
- Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. Hollenberg, N.K., Swartz, S.L., Passan, D.R., Williams, G.H. N. Engl. J. Med. (1979)
- Nonimmunological production of leukotrienes induced by platelet-activating factor. Voelkel, N.F., Worthen, S., Reeves, J.T., Henson, P.M., Murphy, R.C. Science (1982)
- Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. Walmrath, D., Ghofrani, H.A., Rosseau, S., Schütte, H., Cramer, A., Kaddus, W., Grimminger, F., Bhakdi, S., Seeger, W. J. Exp. Med. (1994)
- Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). Wong, D.A., Kita, Y., Uozumi, N., Shimizu, T. J. Exp. Med. (2002)
- ATP-dependent K+ channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs. Wiener, C.M., Dunn, A., Sylvester, J.T. J. Clin. Invest. (1991)
- Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Reubi, J.C., Gugger, M., Waser, B., Schaer, J.C. Cancer Res. (2001)
- Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor. Costoli, T., Sgoifo, A., Stilli, D., Flugge, G., Adriani, W., Laviola, G., Fuchs, E., Pedrazzini, T., Musso, E. Neuroscience and biobehavioral reviews. (2005)
- Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Walther, D.J., Peter, J.U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C.S., Ahnert-Hilger, G., Bader, M. Cell (2003)
- Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. Moliterno, D.J., Willard, J.E., Lange, R.A., Negus, B.H., Boehrer, J.D., Glamann, D.B., Landau, C., Rossen, J.D., Winniford, M.D., Hillis, L.D. N. Engl. J. Med. (1994)
- Local effect of serotonin released during coronary angioplasty. Golino, P., Piscione, F., Benedict, C.R., Anderson, H.V., Cappelli-Bigazzi, M., Indolfi, C., Condorelli, M., Chiariello, M., Willerson, J.T. N. Engl. J. Med. (1994)
- Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. Hilsted, J., Richter, E., Madsbad, S., Tronier, B., Christensen, N.J., Hildebrandt, P., Damkjaer, M., Galbo, H. N. Engl. J. Med. (1987)
- Coronary vasoconstriction caused by indomethacin. O'Brien, W.M. N. Engl. J. Med. (1982)
- Responses of coronary arteries of cardiac transplant patients to acetylcholine. Fish, R.D., Nabel, E.G., Selwyn, A.P., Ludmer, P.L., Mudge, G.H., Kirshenbaum, J.M., Schoen, F.J., Alexander, R.W., Ganz, P. J. Clin. Invest. (1988)
- Transit time heterogeneity in canine small intestine: significance for oxygen transport. Connolly, H.V., Maginniss, L.A., Schumacker, P.T. J. Clin. Invest. (1997)
- Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. Chang, S.W., Feddersen, C.O., Henson, P.M., Voelkel, N.F. J. Clin. Invest. (1987)
- Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Goldstein, D.J., Roon, K.I., Offen, W.W., Ramadan, N.M., Phebus, L.A., Johnson, K.W., Schaus, J.M., Ferrari, M.D. Lancet (2001)
- Prostaglandins and prostaglandin inhibitors in ischemic heart disease. Pitt, B., Shea, M.J., Romson, J.L., Lucchesi, B.R. Ann. Intern. Med. (1983)
- Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Marin-Grez, M., Fleming, J.T., Steinhausen, M. Nature (1986)
- Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Manning, P.T., Schwartz, D., Katsube, N.C., Holmberg, S.W., Needleman, P. Science (1985)
- Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Kloog, Y., Ambar, I., Sokolovsky, M., Kochva, E., Wollberg, Z., Bdolah, A. Science (1988)
- Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. Kurihara, Y., Kurihara, H., Oda, H., Maemura, K., Nagai, R., Ishikawa, T., Yazaki, Y. J. Clin. Invest. (1995)
- ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. Thomas, G.D., Hansen, J., Victor, R.G. J. Clin. Invest. (1997)
- RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles. Mogford, J.E., Davis, G.E., Meininger, G.A. J. Clin. Invest. (1997)
- Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. Archer, S.L., Souil, E., Dinh-Xuan, A.T., Schremmer, B., Mercier, J.C., El Yaagoubi, A., Nguyen-Huu, L., Reeve, H.L., Hampl, V. J. Clin. Invest. (1998)
- Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Simonneau, G., Escourrou, P., Duroux, P., Lockhart, A. N. Engl. J. Med. (1981)
- Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Marrero, M.B., Schieffer, B., Paxton, W.G., Heerdt, L., Berk, B.C., Delafontaine, P., Bernstein, K.E. Nature (1995)
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Ames, R.S., Sarau, H.M., Chambers, J.K., Willette, R.N., Aiyar, N.V., Romanic, A.M., Louden, C.S., Foley, J.J., Sauermelch, C.F., Coatney, R.W., Ao, Z., Disa, J., Holmes, S.D., Stadel, J.M., Martin, J.D., Liu, W.S., Glover, G.I., Wilson, S., McNulty, D.E., Ellis, C.E., Elshourbagy, N.A., Shabon, U., Trill, J.J., Hay, D.W., Ohlstein, E.H., Bergsma, D.J., Douglas, S.A. Nature (1999)
- Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Armstrong, J.M., Blackwell, G.J., Flower, R.J., McGiff, J.C., Mullane, K.M., Vane, J.R. Nature (1976)
- Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Iwamoto, T., Kita, S., Zhang, J., Blaustein, M.P., Arai, Y., Yoshida, S., Wakimoto, K., Komuro, I., Katsuragi, T. Nat. Med. (2004)
- Contribution of endogenous generation of endothelin-1 to basal vascular tone. Haynes, W.G., Webb, D.J. Lancet (1994)
- Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Haynes, W.G., Strachan, F.E., Webb, D.J. Circulation (1995)
- Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Edvinsson, L., Ekman, R., Jansen, I., Ottosson, A., Uddman, R. Ann. Neurol. (1987)
- Endothelin receptors and calcium signaling. Pollock, D.M., Keith, T.L., Highsmith, R.F. FASEB J. (1995)
- Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. Nishikawa, K., Morrison, A., Needleman, P. J. Clin. Invest. (1977)
- Adenosine and ATP: traffic regulators in the kidney. Kriz, W. J. Clin. Invest. (2004)
- Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty. Fischell, T.A., Bausback, K.N., McDonald, T.V. J. Clin. Invest. (1990)
- Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. De Nicola, L., Blantz, R.C., Gabbai, F.B. J. Clin. Invest. (1992)
- Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Curtis, J.J., Luke, R.G., Dubovsky, E., Diethelm, A.G., Whelchel, J.D., Jones, P. Lancet (1986)